Summer 2026
Firmware Engineer Intern
Posted on 6/2/2026
Fluxergy
51-200 employees
Portable diagnostic platform for rapid tests
Compensation Overview
$20/hr
Irvine, CA, USA
In Person
On-site in Irvine, CA; 30-40 hours per week.
 Software Engineering (1) |
|---|
- Current enrollment in a Bachelor’s or Master’s degree program in Computer Engineering or Electrical Engineering or a related technical discipline
- Assist with environment setup and embedded system configuration activities
- Develop an understanding of MK14 daughter board architecture and system functionality
- Support test harness development and execution for firmware validation
- Review hardware datasheets and technical specifications to support development activities
- Contribute to technical documentation and maintain organized engineering records
- Participate in unit testing and firmware verification efforts
- Assist with debugging, error handling, and logging implementation
- Collaborate with engineers to identify opportunities to improve firmware development speed and efficiency
- Support troubleshooting and root cause analysis of firmware and hardware integration issues
- Previous experience with firmware or embedded systems development
- Familiarity with hardware debugging tools and workflows
- Understanding of microcontrollers, communication protocols, or board-level systems
- Experience with unit testing or embedded software validation
- Exposure to version control tools such as Git
Fluxergy creates a portable diagnostic platform that lets healthcare providers, veterinarians (including equine), and food-safety teams run multiple diagnostic tests on a single device, delivering rapid results at point-of-care. The system combines the device with disposable test kits to perform various tests, from molecular assays like COVID-19 to other health and safety checks, and is designed for fast, on-site decision-making. Fluxergy differentiates itself by offering industry-specific applications and a scalable, end-to-end solution (device plus kits) that targets diverse PoC settings, backed by partnerships and validated through collaborations with institutions such as Mass General Brigham. The company aims to expand production and adoption to set new benchmarks in how quickly and reliably laboratory testing can be done in real-world environments.
Company Size
51-200
Company Stage
Series C
Total Funding
$49.5M
Headquarters
Irvine, California
Founded
2011
Simplify's Take
What believers are saying
- NIAID partnership enhances STI and vaginosis POC diagnostics on Fluxergy platform.
- EHV-1 PCR assay validated for equine testing, enabling in-house revenue retention.
- 70,000 sqft Irvine facility scales microfluidic manufacturing for growing demand.
What critics are saying
- Cepheid GeneXpert erodes market share with FDA-cleared STI panels in 6-12 months.
- BioFire FilmArray captures equine pathogen panels, outcompeting Fluxergy in 12-18 months.
- FDA clearance failure confines Fluxergy to veterinary markets in 12-24 months.
What makes Fluxergy unique
- Fluxergy's open platform runs molecular, immunoassay, chemistry, and cytometry on one analyzer.
- Portable FluxergySearch consolidates lab tests using fluorescence and imaging cytometry sensors.
- In-house PCR platform adopted in 80+ veterinary labs across US, Canada, and EU since 2022.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Fluxergy who can refer or advise you
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Paid Vacation
Paid Sick Leave
Paid Holidays
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -2%2 year growth
↑ 0%Fluxergy partners with National Institutes of Health.
Fluxergy started its commercial launch of its in-house PCR platform in late 2022 and is now being used in over 80 veterinary labs and referral hospitals in the US, Canada and EU.
"We are proud to offer an on-site solution and comprehensive laboratory training that can make a difference in how care providers navigate preventative and responsive pathogen testing.". .
IRVINE, CA., July 2, 2020 – California-based Fluxergy will work with Mass General Brigham (MGB), a major health system in Massachusetts, to further evaluate Fluxergy’s innovative Research Use Only (RUO) COVID-19 testing platform, designed to deliver accurate PCR test results in under one hour.
In March, Fluxergy announced that it was similarly working with a team at the University of California, San Diego, to evaluate its system for COVID-19 testing.